Free Trial

Teleflex Incorporated (NYSE:TFX) Receives $252.50 Consensus Price Target from Analysts

Teleflex logo with Medical background

Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $252.50.

Several equities analysts have issued reports on TFX shares. Truist Financial decreased their price objective on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a research note on Wednesday, December 18th. Mizuho decreased their price objective on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Royal Bank of Canada reduced their target price on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a report on Monday, December 16th.

View Our Latest Report on TFX

Teleflex Stock Performance

NYSE TFX traded down $0.17 during trading hours on Thursday, hitting $167.44. The company had a trading volume of 518,347 shares, compared to its average volume of 521,420. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex has a 1-year low of $166.76 and a 1-year high of $256.85. The company has a market cap of $7.78 billion, a PE ratio of 33.29, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. The business has a 50 day moving average of $178.15 and a 200-day moving average of $209.23.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. raised its holdings in Teleflex by 4.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after purchasing an additional 261,279 shares in the last quarter. Janus Henderson Group PLC raised its holdings in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. State Street Corp raised its holdings in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after purchasing an additional 21,291 shares in the last quarter. Geode Capital Management LLC raised its holdings in Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after purchasing an additional 8,307 shares in the last quarter. Finally, Cooke & Bieler LP raised its holdings in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after purchasing an additional 195,150 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Analyst Recommendations for Teleflex (NYSE:TFX)

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines